Functional subsensitivity of 5-HT(2A) and 5-HT(2C) receptors mediating hyperthermia following acute and chronic treatment with 5-HT(2A/2C) receptor antagonists

Psychopharmacology

Volumn 130, Issue 2, 1997, Pages 144-151

  Mazzola Pomietto, Pascale ^a   Aulakh, Charanjit S ^a   Tolliver, Teresa ^a   Murphy, Dennis L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

( )1 (2,5 Dimethoxy 4 iodophenyl) 2 aminopropane; m Chlorophenylpiperazine; Mesulergine; Metergoline; Mianserin; Ritanserin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; MESULERGINE; METERGOLINE; MIANSERIN; RITANSERIN; SEROTONIN 1C RECEPTOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG SENSITIVITY; HYPERTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030893740     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050222     Document Type: Article

References (38)

1. Alper RH (1990) Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Neuroendocrinology 51: 255-260
2. Aulakh CS, Hill JL, Murphy DL (1992) Effects of various serotonin receptor subtype selective antagonists alone and on m-CPP-induced neuroendocrine changes in rats. J Pharmacol Exp Ther 263: 588-595
3. 2A receptors. J Pharmacol Exp Ther 270: 127-132
4. 2C receptors, respectively. Neuropsychopharmacology 13: 1-8
5. 2C receptor-mediated hyperthermia in Fawn-hooded rats. Eur J Pharmacol 282: 65-70
6. Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125: 2664-2669
7. 1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants. Psychopharmacology 105: 219-224
8. Blackshear MA, Sanders-Bush E (1982) Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol Exp Ther 221: 303-308
9. Blackshear MA, Friedman RL, Sanders-Bush E (1983) Acute and chronic effects of serotonin (5-HT) antagonists on serotonin binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 324: 125-129
10. 2 binding site. J Neurosci 6: 3669-3675
11. Conn PJ, Sanders-Bush E (1987) Central serotonin receptors: effector systems, physiological roles and regulation. Psychopharmacology 92: 267-277
12. Fuller RW (1990) Serotonin receptors and neuroendocrine responses. Neuropsychopharmacology 3: 495-502
13. 2 receptors. Eur J Pharmacol 179: 103-109
14. 2 receptor-mediated headtwitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83: 235-242
15. Hartig PR (1989) Molecular biology of 5-HT receptors. Trends Pharmacol Sci 10: 64-69
16. 1 recognition sites. J Recept Res 8: 59-81
17. 1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn-Schmiedeberg's Arch Pharmacol 339: 252-258
18. Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14: 233-236
19. Julius D, MacDermott AB, Axel R, Jessell TM (1988) Molecular characterization of a functional cDNA encoding the serotonin 1C receptor. Science 241: 558-564
20. 1C receptors. Br J Pharmacol 94: 137-147
21. 1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br J Pharmacol 103: 2016-2020
22. Labrecque J, Fargin A, Bouvier M, Chidiac P, Dennis M (1995) Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Mol Pharmacol 48: 150-159
23. Leysen J (1984) Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites. Neuropharmacology 23: 247-254
24. 2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology 88:434-444
25. 2A receptors. Psychopharmacology 117: 193-199
26. 2C receptors. Psychopharmacology 123: 333-339
27. Miller RL, DeVane CL (1986) Analysis of trazodone and m-chlorophenylpiperazine in plasma and brain tissue by high-performance liquid chromatography. J Chromatogr 374: 388-393
28. 1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Neurosci Lett 115: 74-80
29. 1C receptors by serotonergic drugs in the rat. Gen Pharmacol 25: 1279-1284
30. 1C/2 receptor agonists and antagonists. Eur J Pharmacol [Mol Pharmacol Sec] 244: 1-5
31. 2 receptor. EMBO J 7: 4135-4140
32. 2 receptor binding without altering 5-HT, receptor mRNA levels. Eur J Pharmacol 207: 169-172
33. 1C serotonin receptor levels. Methodology and mechanisms. Neuropsychopharmacology 3[5-6]: 427-433
34. 3H-serotonin binding and functional studies in the rat. Brain Res 189: 449-457
35. 2 antagonists block serotonin 5-HT!C receptors in the choroid plexus. J Pharmacol Exp Ther 247: 169-173
36. 2 binding sites after mianserin: comparison of loss of sites and brain levels of drug. Eur J Pharmacol 133: 199-204
37. 2 antagonists in rats. Psychopharmacology 94: 342-346
38. 2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior. J Pharmacol Exp Ther 254: 484-488